Brand-specific enhanced safety surveillance of GSK’s Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season-Reference-Cited by-同舟云学术

Brand-specific enhanced safety surveillance of GSK’s Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season

Published:2020-03-02 Issue:8 Volume:16 Page:1762-1771
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

de Lusignan Simon¹²^ORCID,Damaso Silvia³^ORCID,Ferreira Filipa¹^ORCID,Byford Rachel¹^ORCID,McGee Christopher¹²,Pathirannehelage Sameera¹^ORCID,Shende Vishvesh⁴,Yonova Ivelina¹^ORCID,Schmidt Alexander⁵^ORCID,Schuind Anne⁵^ORCID,Dos Santos Gael³^ORCID

Affiliation:

1. University of Surrey, Guildford, UK

2. Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC), London, UK

3. GSK, Wavre, Belgium

4. VPN Consultancy Limited (on behalf of GSK), London, UK

5. GSK, Rockville, MD, USA

Funder

GlaxoSmithKline foundation

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2019.1705112

Reference28 articles.

1. World Health Organisation (WHO). Influenza - burden of disease. [Accessed 2018 July]. http://www.who.int/influenza/surveillance_monitoring/bod/en/.

2. European Centre for Disease Prevention and Control (ECDC). Factsheet about seasonal influenza. [Accessed 2018 July]. https://ecdc.europa.eu/en/seasonal-influenza/facts/factsheet.

3. World Health Organisation (WHO). Influenza - WHO recommendations on the composition of influenza virus vaccines. [Accessed 2018 July]. http://www.who.int/influenza/vaccines/virus/recommendations/en/.

4. Planning for a cohort study to investigate the impact and management of influenza in pregnancy in a future pandemic

5. Influenza A/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced Safety Surveillance of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain During the 2022/2023 Influenza Season;Drug Safety;2024-06-29

2. An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014–2022) Following the Introduction of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older;Drug Safety;2024-03-14

3. Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series study;Journal of the Royal Society of Medicine;2023-11-03

4. The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review;J;2023-04-17

5. Chronic stage magnetic resonance imaging findings in patients with shoulder injury related to vaccine administration (SIRVA);Skeletal Radiology;2023-04-03